The state of New Hampshire currently has 1 active clinical trials seeking participants for Alzheimer's Disease research studies. These trials are conducted in various cities, including Lebanon, Manchester, Nashua and Portsmouth.
Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's Disease
Recruiting
The purpose of this study is to assess the effectiveness, safety, and tolerability of BMS-986446 an Anti-MTBR Tau Monoclonal Antibody in participants with Early Alzheimer's Disease.
Gender:
All
Ages:
Between 50 years and 80 years
Trial Updated:
03/26/2024
Locations: ActivMed Practices & Research, Inc. - Portsmouth, Portsmouth, New Hampshire
Conditions: Alzheimer Disease, Early Onset